共 159 条
[1]
Llovet JM(1999)Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials Hepatology 29 62-67
[2]
Bustamante J(2000)Natural history of inoperable hepatocellular carcinoma: estrogen receptors’ status in the tumor is the strongest prognostic factor for survival Hepatology 32 233-238
[3]
Castells A(2004)The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma Liver Transplant 10 S115-S120
[4]
Vilana R(2012)Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial J Hepatol 57 821-829
[5]
Ayuso Mdel C(2009)Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion J Gastroenterol Hepatol 24 806-814
[6]
Sala M(1995)Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization AJR Am J Roentgenol 165 315-321
[7]
Villa E(2005)Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis J Vasc Interv Radiol 16 1653-1659
[8]
Moles A(2005)Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study Surgery 137 403-410
[9]
Ferretti I(2009)Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma? Surgery 145 9-19
[10]
Buttafoco P(2011)Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation Hepatology 54 868-878